Clinical trial
Rectal and Oral Omeprazole Treatment of Reflux Disease in Infants.
NCT00226044 · Rijnstate Hospital, Other · Completed
Key facts
| NCT number | NCT00226044 |
|---|---|
| Title | Rectal and Oral Omeprazole Treatment of Reflux Disease in Infants. |
| Official title | Rectal and Oral Omeprazole Treatment of Gastroesophageal Reflux in Infants With Esophageal Atresia or Congenital Diaphragmatic Hernia; A Pharmacodynamic and Pharmacokinetic Study. |
| Lead sponsor | Rijnstate Hospital, Other |
| Collaborators | Erasmus Medical Center |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Gastroesophageal Reflux, Esophageal Atresia, Hernia, Diaphragmatic |
| Intervention type | Drug |
| Interventions | Omeprazole rectally 1mg/kg |
| Enrollment | 17 |
| Start date | Sep 1, 2005 |
| Primary completion | Sep 1, 2016 |
| Completion | Sep 1, 2017 |
| First posted | Sep 26, 2005 |
| Last update posted | Oct 7, 2019 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: